HIGHFDA DEVICE

Focalyx Technologies Recalls Software Device Over Patient Safety Risks

Focalyx Technologies issued a recall for its Focalyx Fusion software device on December 23, 2025. The device may malfunction with Windows 10, potentially causing patient harm during prostate biopsies. Users must stop using the device immediately until it is validated with Windows 11.

Official notice
Focalyx TechnologiesHealth & Personal CareMedical DevicesUDI-DI: 00860003552001. Software Versions: 1.31.51.6. Serial Numbers: IF-FF-B-1-22080504

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DEVICE
Recall date
December 23, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
December 23, 2025
Hazard Level
HIGH
Brand
Focalyx Technologies
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Medical Devices; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
Focalyx Technologies
Product type
Software Device
Model numbers
UDI-DI: 00860003552001. Software Versions: 1.3, 1.5, 1.6. Serial Numbers: IF-FF-B-1-22080504, IF-FF-B-1-TPAA998118, IF-FF-B-1-351238, IF-FF-B-1-TPAB081335, IF-FF-B-1-22080508, IF-FF-B-1-TPAB200331 +12 more
Sold at
Multiple Retailers
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    December 23, 2025

  2. Reported by FDA DEVICE

    February 11, 2026

  3. RecallRadar source check

    February 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Software device that is an accessory for image-guided interventional and diagnostic procedures involving prostate has accessories that may not function properly with Windows 10, which may cause patient harm during biopsy or cause treatment/therapy delays, so firm is recommending stop use until device is verified/validated with Windows 11.

What You Should Do

Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Focalyx Technologies, LLC. or your healthcare provider for instructions. Notification method: Letter

About This Product

Focalyx Fusion is a software device used as an accessory for image-guided interventional and diagnostic procedures concerning prostate health. It is typically utilized in medical settings to assist in biopsy procedures and other diagnostic functions.

Why This Is Dangerous

This device may not operate properly with Windows 10, which could lead to significant risks during medical procedures such as biopsies. Such malfunctions could delay treatment and lead to adverse patient outcomes.

Industry Context

This recall is not part of a broader industry pattern.

Real-World Impact

Patients and healthcare providers may face delays in procedures, which could impact treatment schedules and health outcomes.

Practical Guidance

How to identify if yours is affected

  1. Check the device's software version and serial number against the recall list.
  2. Verify if the software is running on Windows 10.
  3. Contact your healthcare provider for confirmation if unclear.

Where to find product info

Serial numbers and software versions can typically be found on the device's packaging or user manual.

What timeline to expect

Expect a refund or replacement to be processed within 4-6 weeks after your request.

If the manufacturer is unresponsive

  • Follow up with Focalyx Technologies via phone or email.
  • Document all interactions and responses.

How to prevent similar issues

  • Ensure compatibility with the latest software before purchasing medical devices.
  • Check for recalls and safety updates regularly.

Documentation advice

Keep a record of any communications with the manufacturer and retain all documentation related to the recall.

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

The Focalyx Fusion software device is designed for image-guided interventional and diagnostic procedures involving the prostate. The recall affects 18 units distributed worldwide, including New York, Massachusetts, Florida, Spain, Venezuela, and the Dominican Republic.

Key Facts

  • Recall date: December 23, 2025
  • Reported date: February 11, 2026
  • Total quantity recalled: 18
  • Device may malfunction with Windows 10
  • Potential risk: patient harm during procedures

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
OTHER

Product Classification

Product Details

Model Numbers
UDI-DI: 00860003552001. Software Versions: 1.3
1.5
1.6. Serial Numbers: IF-FF-B-1-22080504
IF-FF-B-1-TPAA998118
IF-FF-B-1-351238
+15 more
Affected States
ALL
Report Date
February 11, 2026
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

Taro Pharmaceuticals Withdraws Diclofenac Sodium Gel Over Viscosity Issues

Taro Pharmaceuticals announced a market withdrawal of Diclofenac Sodium, Topical Gel, 3% on January 27, 2026. The withdrawal stems from out of specification viscosity results. Healthcare providers and consumers should stop using the product immediately.

BEEKEEPER'S NATURALS USA
Microbial Contamination
Read more
Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more